Anakinra (IL-1R antagonist) lowers pulmonary artery pressure in a neonatal surfactant depleted piglet model

Pediatric Pulmonology

Volumn 43, Issue 9, 2008, Pages 851-857

  Chada, Martin ^a   Nögel, Stephanie ^a   Schmidt, Ana Marija ^a   Rückel, Aline ^a   Bosselmann, Stephan ^a   Walther, Julia ^a   Papadopoulos, Thomas ^b   Von Der Hardt, Katharina ^a   Dötsch, Jörg ^a   Rascher, Wolfgang ^a   Kandler, Michael A ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Acute respiratory distress syndrome; Infant; Interleukin 1 receptor antagonist; Pulmonary hypertension

Indexed keywords

BETA ACTIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INFLAMMATION; LUNG ARTERY PRESSURE; LUNG INJURY; LUNG LAVAGE; LUNG MECHANICS; MALE; NEWBORN PERIOD; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SWINE;

ACUTE LUNG INJURY; ANIMALS; ANIMALS, NEWBORN; BLOOD PRESSURE; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; PULMONARY ARTERY; PULMONARY SURFACTANTS; RESPIRATORY MECHANICS; SWINE;

EID: 50849107401     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20851     Document Type: Article

References (29)

1. Kaisers U, Busch T, Deja M, Donaubauer B, Falke KJ. Selective pulmonary vasodilation in acute respiratory distress syndrome. Crit Care Med 2003;31:S337-S342.
2. von der Hardt K, Kandler MA, Popp K, Schoof E, Chada M, Rascher W, Dötsch J. Aerosolized adrenomedullin suppresses pulmonary transforming growth factor-beta1 and interleukin-1 beta gene expression in vivo. Eur J Pharmacol 2002;457:71-76.
3. von der Hardt K, Schoof E, Kandler MA, Dötsch J, Rascher W. Aerosolized perfluorocarbon suppresses early pulmonary inflammatory response in a surfactant-depleted piglet model. Pediatr Res 2002;51:177-182.
4. Tuder RM, Voelkel NF. Pulmonary hypertension and inflammation. J Lab Clin Med 1998;132:16-24.
5. Kandler MA, von der Hardt K, Schoof E, Dötsch J, Rascher W. Persistent improvement of gas exchange and lung mechanics by aerosolized perfluorocarbon. Am J Respir Crit Care Med 2001;164:31-35.
6. Schoof E, von der Hardt K, Kandler MA, Abendroth F, Papadopoulos T, Rascher W, Dötsch J. Aerosolized perfluorocarbon reduces adhesion molecule gene expression and neutrophil sequestration in acute respiratory distress. Eur J Pharmacol 2002;457:195-200.
7. von der Hardt K, Kandler MA, Brenn G, Scheuerer K, Schoof E, Dötsch J, Rascher W. Comparison of aerosol therapy with different perfluorocarbons in surfactant-depleted animals. Crit Care Med 2004;32:1200-1206.
8. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998;16:27-55.
9. Fleischmann R, Stern R, Iqbal I. Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis. Expert Opin Biol Ther 2004;4:1333-1344.
10. Gouze JN, Gouze E, Palmer GD, Liew VS, Pascher A, Betz OB, Thornhill TS, Evans CH, Grodzinsky AJ, Ghivizzani SC. A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer. Arthritis Res Ther 2003;5:R301-R309.
11. von der Hardt K, Kandler MA, Chada M, Cubra A, Schoof E, Amann K, Rascher W, Dötsch J. Brief adrenomedullin inhalation leads to sustained reduction of pulmonary artery pressure. Eur Respir J 2004;24:615-623.
12. Kandler MA, von der Hardt K, Mahfoud S, Chada M, Schoof E, Papadopoulos T, Rascher W, Dötsch J. Pilot intervention: aerosolized adrenomedullin reduces pulmonary hypertension. J Pharmacol Exp Ther 2003;306:1021-1026.
13. Quintel M, Heine M, Hirschl RB, Tillmanns R, Wessendorf V. Effects of partial liquid ventilation on lung injury in a model of acute respiratory failure: a histologic and morphometric analysis. Crit Care Med 1998;26:833-843.
14. Voelkel NF, Tuder RM, Bridges J, Arend WP. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am J Respir Cell Mol Biol 1994;11:664-675.
15. Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003;22:358-363.
16. El-Haroun H, Bradbury D, Clayton A, Knox AJ. Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2 and 4. Circ Res 2004;94:353-361.
17. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990;343:341-346.
18. Selig W, Tocker J. Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs. Eur J Pharmacol 1992;213:331-336.
19. Leff JA, Bodman ME, Cho OJ, Rohrbach S, Reiss OK, Vannice JL, Repine JE. Post-insult treatment with interleukin-1 receptor antagonist decreases oxidative lung injury in rats given intratracheal interleukin-1. Am J Respir Crit Care Med 1994;150:109-112.
20. Frank JA, Pittet JF, Wray C, Matthay MA. Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade. Thorax 2008;63:147-153.
21. Sun D, Zhao M, Ma D, Liao S, Di C. Protective effect of interleukin-1 receptor antagonist on oleic acid-induced lung injury. Chin Med J (Engl) 1996;109:522-526.
22. Narimanbekov IO, Rozycki HJ. Effect of IL-1 blockade on inflammatory manifestations of acute ventilator-induced lung injury in a rabbit model. Exp Lung Res 1995;21:239-254.
23. Abraham E, Allbee J. Effects of therapy with interleukin-1 receptor antagonist on pulmonary cytokine expression following hemorrhage and resuscitation. Lymphokine Cytokine Res 1994;13:343-347.
24. von der Hardt K, Kandler MA, Fink L, Schoof E, Dötsch J, Bohle RM, Rascher W. Laser-assisted microdissection and real-time PCR detect anti-inflammatory effect of perfluorocarbon. Am J Physiol Lung Cell Mol Physiol 2003;285:L55-L62.
25. Watson ML, Smith D, Bourne AD, Thompson RC, Westwick J. Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol 1993;8:365-369.
26. DeForge LE, Tracey DE, Kenney JS, Remick DG. Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopolysaccharide- stimulated human whole blood. Am J Pathol 1992;40:1045-1054.
27. Imamura S, Matsukawa A, Ohkawara S, Kagayama M, Yoshinaga M. Involvement of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-8, and interleukin-1 receptor antagonist in acute lung injury caused by local Shwartzman reaction. Pathol Int 1997;47:16-24.
28. Yehuda A, Schwarz YA, Amin RS, Stark JM, Trapnell BC, Wilmott RW. Interleukin-1 receptor antagonist inhibits interleukin-8 expression in A549 respiratory epithelial cells infected in vitro with a replication-deficient recombinant adenovirus vector. Am J Respir Cell Mol Biol 1999;21:388-394.
29. Ulich TR, Yin SM, Guo KZ, del Castillo J, Eisenberg SP, Thompson RC. The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation. Am J Pathol 1991;138:521-524.